PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology ...

Revenue of $3.3 Million, a 12% Increase Compared to Prior Year ~~ Interim Analysis from MAINSAIL Study Reinforces Safety Profile, Effectiveness and Confirmation of Fusion ~~ Catamaran® ...

A new study found that women are less comfortable calling triple-0 when experiencing symptoms of a heart attack, providing a ...

Compare the size of up to three phones side-by-side or on top of each other.